Thromboembolism in patients with atrial fibrillation with and without left atrial thrombus documented by transesophageal echocardiography

American Journal of Therapeutics

Volumn 16, Issue 5, 2009, Pages 385-392

  Nair, Chandra K ^a   Holmberg, Mark J ^a   Aronow, Wilbert S ^b   Shen, Xuedong ^a   Li, Huagui ^a   Lakkireddy, Dhanunjay ^a  

^a CREIGHTON UNIVERSITY CARDIAC CENTER   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Atrial fibrillation; Cerebrovascular events; Left atrial thrombus; Thromboembolism; Transesophageal echocardiography; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; STROKE; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; FEMALE; HEART ATRIA; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; THROMBOEMBOLISM; THROMBOSIS; WARFARIN;

EID: 70349656992     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181727b42     Document Type: Article

References (30)

1. Leung DY, Davidson PM, Cranney GB, et al. Thromboembolic risks of left atrial thrombus detected by transesophageal echocardiography. Am J Cardiol. 1997;79: 626-629.
2. Manning WJ, Silverman DI, Keighley CS, et al. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4. 5-year study. J Am Coll Cardiol. 1995;25:1354-1361.
3. Corrado G, Santarone M, Beretta S, et al. Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: a single centre 8.5-year experience. Europace. 2000;2:119-126.
4. Corrado G, Tadeo G, Beretta S, et al. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation. Chest. 1999;115:140-143.
5. Klein AL, Grimm RA, Black IW, et al. Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot study. Ann Intern Med. 1997;126:200-209.
6. Woosley R. Antiarrhythmic drugs. In: Fuster V, Alexander RW, O'Rourke RA, eds. Hurst's The Heart, 10th ed. New York, NY: McGraw-Hill Medical Publishing Division; 2001:899.
7. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. Circulation. 2001;104: 2118-2150.
8. Montgomery DH, Ververis JJ, McGorisk G, et al. Natural history of severe atheromatous disease of the thoracic aorta: a transesophageal echocardiographic study. J Am Coll Cardiol. 1996;27:95-101.
9. Bjerkelund CJ, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol. 1969;23: 208-216.
10. Ezekowitz MD, James KE, Nazarian SM, et al. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Circulation. 1995;92:2178-2182.
11. Roy D, Marchand E, Gagne P, et al. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. Am Heart J. 1986;112: 1039-1043.
12. Resnekov L, McDonald L. Complications in 220 patients with cardiac dysrhythmias treated by phased direct current shock, and indications for electroconversion. Br Heart J. 1967;29:926-936.
13. Archer SL, James KE, Kvernen LR, et al. Role of transesophageal echocardiography in the detection of left atrial thrombus in patients with chronic nonrheumatic atrial fibrillation. Am Heart J. 1995;130:287-295.
14. Li-Saw-Hee FL, Blann AD, Lip GY. Effect of fixed lowdose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation. Stroke. 2000;31:828-833.
15. Samsa GP, Matchar DB, Goldstein LB, et al. Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Intern Med. 2000;160:967-973.
16. Klein AL, Grimm RA, Murray RD, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med. 2001; 344:1411-1420.
17. Mayet J, More RS, Sutton GC. Anticoagulation for cardioversion of atrial arrhythmias. Eur Heart J. 1998;19: 548-552.
18. Jung F, DiMarco JP. Treatment strategies for atrial fibrillation. Am J Med. 1998;104:272-286.
19. Mendelson G, Aronow WS. Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke. J Am Geriatr Soc. 1998;46:1423-1424.
20. Nademanee K, Kosar EM. Long-term antithrombotic treatment for atrial fibrillation. Am J Cardiol. 1998;82: 37N-42N. (Pubitemid 28507118)
21. Charles C, Gornick MD. Anticoagulant use in nonvalvular atrial fibrillation: determining risk and choosing the safest course. Postgrad Med. 2000;108:113-126.
22. Black IW, Hopkins AP, Lee LC, et al. Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. Am Heart J. 1993;126:375-381.
23. Jaber WA, Prior DL, Thamilarasan M, et al. Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: a transesophageal echocardiographic study. Am Heart J. 2000;140:150-156.
24. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, II: echocardiographic features of patients at risk. Ann Intern Med. 1992;116:6-12.
25. Blackshear JL, Pearce LA, Asinger RW, et al. Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation: Stroke Prevention in Atrial Fibrillation Investigators. Am J Cardiol. 1993;72:840-843.
26. Rosenthal MS, Halperin JL. Thromboembolism in nonvalvular atrial fibrillation: the answer may be in the ventricle. Int J Cardiol. 1992;37:277-282.
27. Imazio M, Oliaro E, Ferrua S, et al. Surgical treatment of atrial thrombosis: a transesophageal echocardiogram study. Minerva Cardioangiol. 2001;49:279-283.
28. Lee CH, Chen CC, Chern MS. Thrombolytic therapy for acute left atrial thrombus formation in one patient with heart failure and atrial fibrillation. Circ J. 2007;71: 604-607.
29. Ostermayer SH, Reisman M, Kramer PH, et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation. Results from the international multicenter feasibility trials. J Am Coll Cardiol. 2005;46:9-14.
30. Sick PB, Schuler G, Hauptmann KE, et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2007;49:1490-1495.